Sunday, October 6, 2019
A case study Teva Pharmaceutical Industries, Ltd Essay
A case study Teva Pharmaceutical Industries, Ltd - Essay Example The present revenue is $13.9 billion and the net income is $2.000 billion. Labour force is one of the main input for Teva and the current number of employees is 35,089. Comparing the cost structure for innovative and generic cost structure for the year 2005, the net sale was cent percent for the both but the gross profit was lowerà for the generic with respect to the innovative. However, the rate of growth of total sales was higher for generic than the innovative. There was a positive correlation between gross profit and R&d expenses, SG & A expenses (Bank of America Securities). The revenue was gradually increasing til 2005 in U.S., Western Europe and rest of the world (Medical and healthcare marketplace guide). The annual sale of Teva is highest comparing with its all competitors. Teva has sold a large proportion of their total production in U.S.(Medical and healthcare marketplace guide). In number of employees and market capitals, Teva was maintaining the leading position. Comp aring the strategic position with its competitors, we can say that there were considerable differences in case of total market share in U.S., growth in U.S., number of products in U.S. and also the FDA approvals (Medical and healthcare marketplace guide) in 2005. Teva maintained the leading position in all these strategic position as well as in the case of profitability. Revenue growth and net income growth is incomparably higher than its competitors are. In 2005, Teva made a deal with highest value worth $ 7,367 million.à à Ã
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment